0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Insulin Drug Delivery Devices Market Report & Forecast 2022-2028
Published Date: June 2022
|
Report Code: QYRE-Auto-37X10341
Home | Market Reports | Health | Health Conditions | Endocrine Conditions
Global and United States Insulin Drug Delivery Devices Market Report Forecast 2022 2028

Global and United States Insulin Drug Delivery Devices Market Report & Forecast 2022-2028

Code: QYRE-Auto-37X10341
Report
June 2022
109 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.
Market Analysis and Insights: Global and United States Insulin Drug Delivery Devices Market
This report focuses on global and United States Insulin Drug Delivery Devices market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Insulin Drug Delivery Devices market size is estimated to be worth US$ 14710 million in 2022 and is forecast to a readjusted size of US$ 19310 million by 2028 with a CAGR of 4.6% during the review period.

Fully considering the economic change by this health crisis, by Type, Syringes accounting for % of the Insulin Drug Delivery Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.

In United States the Insulin Drug Delivery Devices market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.

Global Insulin Drug Delivery Devices Scope and Market Size
Insulin Drug Delivery Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Insulin Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Insulin Drug Delivery Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Syringes
Insulin Pens
Jet Injectors
Insulin Pumps

Segment by Application

Hospitals
Clinics
Homecare
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas
1 Study Coverage
1.1 Insulin Drug Delivery Devices Product Introduction
1.2 Global Insulin Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Insulin Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Insulin Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.3 United States Insulin Drug Delivery Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Insulin Drug Delivery Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Insulin Drug Delivery Devices Sales in Volume for the Year 2017-2028
1.4 Insulin Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Insulin Drug Delivery Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Insulin Drug Delivery Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Insulin Drug Delivery Devices Market Dynamics
1.5.1 Insulin Drug Delivery Devices Industry Trends
1.5.2 Insulin Drug Delivery Devices Market Drivers
1.5.3 Insulin Drug Delivery Devices Market Challenges
1.5.4 Insulin Drug Delivery Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Insulin Drug Delivery Devices Market Segment by Type
2.1.1 Syringes
2.1.2 Insulin Pens
2.1.3 Jet Injectors
2.1.4 Insulin Pumps
2.2 Global Insulin Drug Delivery Devices Market Size by Type
2.2.1 Global Insulin Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Insulin Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Insulin Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Insulin Drug Delivery Devices Market Size by Type
2.3.1 United States Insulin Drug Delivery Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Insulin Drug Delivery Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Insulin Drug Delivery Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Insulin Drug Delivery Devices Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Homecare
3.1.4 Others
3.2 Global Insulin Drug Delivery Devices Market Size by Application
3.2.1 Global Insulin Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Insulin Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Insulin Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Insulin Drug Delivery Devices Market Size by Application
3.3.1 United States Insulin Drug Delivery Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Insulin Drug Delivery Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Insulin Drug Delivery Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Insulin Drug Delivery Devices Competitor Landscape by Company
4.1 Global Insulin Drug Delivery Devices Market Size by Company
4.1.1 Top Global Insulin Drug Delivery Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Insulin Drug Delivery Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Insulin Drug Delivery Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Insulin Drug Delivery Devices Price by Manufacturer (2017-2022)
4.2 Global Insulin Drug Delivery Devices Concentration Ratio (CR)
4.2.1 Insulin Drug Delivery Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Insulin Drug Delivery Devices in 2021
4.2.3 Global Insulin Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Insulin Drug Delivery Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Insulin Drug Delivery Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Insulin Drug Delivery Devices Product Type
4.3.3 Date of International Manufacturers Enter into Insulin Drug Delivery Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Insulin Drug Delivery Devices Market Size by Company
4.5.1 Top Insulin Drug Delivery Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Insulin Drug Delivery Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Insulin Drug Delivery Devices Sales by Players (2020, 2021 & 2022)
5 Global Insulin Drug Delivery Devices Market Size by Region
5.1 Global Insulin Drug Delivery Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Insulin Drug Delivery Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Insulin Drug Delivery Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Insulin Drug Delivery Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Insulin Drug Delivery Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Insulin Drug Delivery Devices Sales in Value by Region: 2017-2022
5.3.2 Global Insulin Drug Delivery Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Insulin Drug Delivery Devices Market Size YoY Growth 2017-2028
6.1.2 North America Insulin Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Insulin Drug Delivery Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Insulin Drug Delivery Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Insulin Drug Delivery Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Insulin Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Insulin Drug Delivery Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Insulin Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Insulin Drug Delivery Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Insulin Drug Delivery Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Corporation Information
7.1.2 Novo Nordisk Description and Business Overview
7.1.3 Novo Nordisk Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novo Nordisk Insulin Drug Delivery Devices Products Offered
7.1.5 Novo Nordisk Recent Development
7.2 Sanofi
7.2.1 Sanofi Corporation Information
7.2.2 Sanofi Description and Business Overview
7.2.3 Sanofi Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sanofi Insulin Drug Delivery Devices Products Offered
7.2.5 Sanofi Recent Development
7.3 BD
7.3.1 BD Corporation Information
7.3.2 BD Description and Business Overview
7.3.3 BD Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 BD Insulin Drug Delivery Devices Products Offered
7.3.5 BD Recent Development
7.4 Eli Lilly
7.4.1 Eli Lilly Corporation Information
7.4.2 Eli Lilly Description and Business Overview
7.4.3 Eli Lilly Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly Insulin Drug Delivery Devices Products Offered
7.4.5 Eli Lilly Recent Development
7.5 Medtronic
7.5.1 Medtronic Corporation Information
7.5.2 Medtronic Description and Business Overview
7.5.3 Medtronic Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Medtronic Insulin Drug Delivery Devices Products Offered
7.5.5 Medtronic Recent Development
7.6 Beta Bionics
7.6.1 Beta Bionics Corporation Information
7.6.2 Beta Bionics Description and Business Overview
7.6.3 Beta Bionics Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Beta Bionics Insulin Drug Delivery Devices Products Offered
7.6.5 Beta Bionics Recent Development
7.7 Dance Biopharm
7.7.1 Dance Biopharm Corporation Information
7.7.2 Dance Biopharm Description and Business Overview
7.7.3 Dance Biopharm Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Dance Biopharm Insulin Drug Delivery Devices Products Offered
7.7.5 Dance Biopharm Recent Development
7.8 Roche
7.8.1 Roche Corporation Information
7.8.2 Roche Description and Business Overview
7.8.3 Roche Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Roche Insulin Drug Delivery Devices Products Offered
7.8.5 Roche Recent Development
7.9 Tandem Diabetes Care
7.9.1 Tandem Diabetes Care Corporation Information
7.9.2 Tandem Diabetes Care Description and Business Overview
7.9.3 Tandem Diabetes Care Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Tandem Diabetes Care Insulin Drug Delivery Devices Products Offered
7.9.5 Tandem Diabetes Care Recent Development
7.10 Animas
7.10.1 Animas Corporation Information
7.10.2 Animas Description and Business Overview
7.10.3 Animas Insulin Drug Delivery Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Animas Insulin Drug Delivery Devices Products Offered
7.10.5 Animas Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Insulin Drug Delivery Devices Industry Chain Analysis
8.2 Insulin Drug Delivery Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Insulin Drug Delivery Devices Distributors
8.3 Insulin Drug Delivery Devices Production Mode & Process
8.4 Insulin Drug Delivery Devices Sales and Marketing
8.4.1 Insulin Drug Delivery Devices Sales Channels
8.4.2 Insulin Drug Delivery Devices Distributors
8.5 Insulin Drug Delivery Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Insulin Drug Delivery Devices CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Insulin Drug Delivery Devices Market Trends
    Table 3. Insulin Drug Delivery Devices Market Drivers
    Table 4. Insulin Drug Delivery Devices Market Challenges
    Table 5. Insulin Drug Delivery Devices Market Restraints
    Table 6. Global Insulin Drug Delivery Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Insulin Drug Delivery Devices Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Insulin Drug Delivery Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Insulin Drug Delivery Devices Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Insulin Drug Delivery Devices Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Insulin Drug Delivery Devices Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Insulin Drug Delivery Devices Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Insulin Drug Delivery Devices Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Insulin Drug Delivery Devices Sales Share by Manufacturer, 2017-2022
    Table 15. Global Insulin Drug Delivery Devices Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Insulin Drug Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Insulin Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Drug Delivery Devices as of 2021)
    Table 18. Top Players of Insulin Drug Delivery Devices in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Insulin Drug Delivery Devices Product Type
    Table 20. Date of International Manufacturers Enter into Insulin Drug Delivery Devices Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Insulin Drug Delivery Devices Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Insulin Drug Delivery Devices Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Insulin Drug Delivery Devices Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Insulin Drug Delivery Devices Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Insulin Drug Delivery Devices Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Insulin Drug Delivery Devices Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Insulin Drug Delivery Devices Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Insulin Drug Delivery Devices Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Insulin Drug Delivery Devices Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Insulin Drug Delivery Devices Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Insulin Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Insulin Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Insulin Drug Delivery Devices Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Insulin Drug Delivery Devices Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Insulin Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Insulin Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Insulin Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Insulin Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Insulin Drug Delivery Devices Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Insulin Drug Delivery Devices Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Novo Nordisk Corporation Information
    Table 43. Novo Nordisk Description and Business Overview
    Table 44. Novo Nordisk Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Novo Nordisk Insulin Drug Delivery Devices Product
    Table 46. Novo Nordisk Recent Development
    Table 47. Sanofi Corporation Information
    Table 48. Sanofi Description and Business Overview
    Table 49. Sanofi Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Sanofi Product
    Table 51. Sanofi Recent Development
    Table 52. BD Corporation Information
    Table 53. BD Description and Business Overview
    Table 54. BD Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. BD Product
    Table 56. BD Recent Development
    Table 57. Eli Lilly Corporation Information
    Table 58. Eli Lilly Description and Business Overview
    Table 59. Eli Lilly Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Eli Lilly Product
    Table 61. Eli Lilly Recent Development
    Table 62. Medtronic Corporation Information
    Table 63. Medtronic Description and Business Overview
    Table 64. Medtronic Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Medtronic Product
    Table 66. Medtronic Recent Development
    Table 67. Beta Bionics Corporation Information
    Table 68. Beta Bionics Description and Business Overview
    Table 69. Beta Bionics Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Beta Bionics Product
    Table 71. Beta Bionics Recent Development
    Table 72. Dance Biopharm Corporation Information
    Table 73. Dance Biopharm Description and Business Overview
    Table 74. Dance Biopharm Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Dance Biopharm Product
    Table 76. Dance Biopharm Recent Development
    Table 77. Roche Corporation Information
    Table 78. Roche Description and Business Overview
    Table 79. Roche Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Roche Product
    Table 81. Roche Recent Development
    Table 82. Tandem Diabetes Care Corporation Information
    Table 83. Tandem Diabetes Care Description and Business Overview
    Table 84. Tandem Diabetes Care Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Tandem Diabetes Care Product
    Table 86. Tandem Diabetes Care Recent Development
    Table 87. Animas Corporation Information
    Table 88. Animas Description and Business Overview
    Table 89. Animas Insulin Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. Animas Product
    Table 91. Animas Recent Development
    Table 92. Key Raw Materials Lists
    Table 93. Raw Materials Key Suppliers Lists
    Table 94. Insulin Drug Delivery Devices Customers List
    Table 95. Insulin Drug Delivery Devices Distributors List
    Table 96. Research Programs/Design for This Report
    Table 97. Key Data Information from Secondary Sources
    Table 98. Key Data Information from Primary Sources
List of Figures
    Figure 1. Insulin Drug Delivery Devices Product Picture
    Figure 2. Global Insulin Drug Delivery Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Insulin Drug Delivery Devices Market Size 2017-2028 (US$ Million)
    Figure 4. Global Insulin Drug Delivery Devices Sales 2017-2028 (K Units)
    Figure 5. United States Insulin Drug Delivery Devices Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Insulin Drug Delivery Devices Market Size 2017-2028 (US$ Million)
    Figure 7. United States Insulin Drug Delivery Devices Sales 2017-2028 (K Units)
    Figure 8. United States Insulin Drug Delivery Devices Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Insulin Drug Delivery Devices Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Insulin Drug Delivery Devices Report Years Considered
    Figure 11. Product Picture of Syringes
    Figure 12. Product Picture of Insulin Pens
    Figure 13. Product Picture of Jet Injectors
    Figure 14. Product Picture of Insulin Pumps
    Figure 15. Global Insulin Drug Delivery Devices Market Share by Type in 2022 & 2028
    Figure 16. Global Insulin Drug Delivery Devices Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Insulin Drug Delivery Devices Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Insulin Drug Delivery Devices Sales by Type (2017-2028) & (K Units)
    Figure 19. Global Insulin Drug Delivery Devices Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Insulin Drug Delivery Devices Price by Type (2017-2028) & (USD/Unit)
    Figure 21. United States Insulin Drug Delivery Devices Market Share by Type in 2022 & 2028
    Figure 22. United States Insulin Drug Delivery Devices Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Insulin Drug Delivery Devices Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Insulin Drug Delivery Devices Sales by Type (2017-2028) & (K Units)
    Figure 25. United States Insulin Drug Delivery Devices Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Insulin Drug Delivery Devices Price by Type (2017-2028) & (USD/Unit)
    Figure 27. Product Picture of Hospitals
    Figure 28. Product Picture of Clinics
    Figure 29. Product Picture of Homecare
    Figure 30. Product Picture of Others
    Figure 31. Global Insulin Drug Delivery Devices Market Share by Application in 2022 & 2028
    Figure 32. Global Insulin Drug Delivery Devices Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 33. Global Insulin Drug Delivery Devices Sales Market Share in Value by Application (2017-2028)
    Figure 34. Global Insulin Drug Delivery Devices Sales by Application (2017-2028) & (K Units)
    Figure 35. Global Insulin Drug Delivery Devices Sales Market Share in Volume by Application (2017-2028)
    Figure 36. Global Insulin Drug Delivery Devices Price by Application (2017-2028) & (USD/Unit)
    Figure 37. United States Insulin Drug Delivery Devices Market Share by Application in 2022 & 2028
    Figure 38. United States Insulin Drug Delivery Devices Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 39. United States Insulin Drug Delivery Devices Sales Market Share in Value by Application (2017-2028)
    Figure 40. United States Insulin Drug Delivery Devices Sales by Application (2017-2028) & (K Units)
    Figure 41. United States Insulin Drug Delivery Devices Sales Market Share in Volume by Application (2017-2028)
    Figure 42. United States Insulin Drug Delivery Devices Price by Application (2017-2028) & (USD/Unit)
    Figure 43. North America Insulin Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 44. North America Insulin Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 45. U.S. Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Canada Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Europe Insulin Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 48. Europe Insulin Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 49. Germany Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. France Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. U.K. Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Italy Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Russia Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Asia-Pacific Insulin Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 55. Asia-Pacific Insulin Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 56. China Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Japan Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. South Korea Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. India Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Australia Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Taiwan Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Indonesia Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Thailand Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Malaysia Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Philippines Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Latin America Insulin Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 67. Latin America Insulin Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 68. Mexico Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Brazil Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Argentina Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Middle East & Africa Insulin Drug Delivery Devices Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 72. Middle East & Africa Insulin Drug Delivery Devices Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 73. Turkey Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Saudi Arabia Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 75. U.A.E Insulin Drug Delivery Devices Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 76. Insulin Drug Delivery Devices Value Chain
    Figure 77. Insulin Drug Delivery Devices Production Process
    Figure 78. Channels of Distribution
    Figure 79. Distributors Profiles
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4350
This license allows only one user to access the PDF.

Electronic (PDF)
$6525
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$8700
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Sitagliptin Phosphate API Market Research Report 2022
Global Sitagliptin Phosphate API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-20U11672
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Wearable Blood Glucose Meter Market Research Report 2022
Global Wearable Blood Glucose Meter Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-25N11464
Thu Aug 11 00:00:00 UTC 2022

Add to Cart

Global Laboratory Blood Glucose Analyzers Market Research Report 2022
Global Laboratory Blood Glucose Analyzers Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-36B11563
Mon Aug 08 00:00:00 UTC 2022

Add to Cart

Global Stem Cell Therapy for Diabetes and Related Conditions Market Research Report 2022
Global Stem Cell Therapy for Diabetes and Related Conditions Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-24T11037
Sun Aug 07 00:00:00 UTC 2022

Add to Cart